Cytek Biosciences Reports First Quarter 2024 Financial Results
08 mai 2024 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
30 avr. 2024 17h30 HE
|
Cytek Biosciences, Inc.
Cytek® Biosciences will spotlight its cell analysis solutions and conduct educational workshops/tutorials at CYTO and AAI's IMMUNOLOGY2024
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
29 avr. 2024 09h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the first...
Cytek® Biosciences Names William McCombe Chief Financial Officer
19 mars 2024 08h00 HE
|
Cytek Biosciences, Inc.
Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outlook FREMONT, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Cytek...
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
07 mars 2024 17h30 HE
|
Cytek Biosciences, Inc.
Cytek Biosciences has opened a 50,000-square-foot facility in Wuxi, China to meet the growing worldwide demand for comprehensive cell analysis solutions
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
28 févr. 2024 17h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...
Cytek Biosciences to Participate in Upcoming Investor Conferences
07 févr. 2024 16h10 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
07 févr. 2024 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the fourth...
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
17 janv. 2024 17h30 HE
|
Cytek Biosciences, Inc.
Cytek Biosciences has signed an agreement with The Centre for Genomic Regulation and the Pompeu Fabra University to accelerate scientific discoveries.
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
08 janv. 2024 09h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the...